Treating Niemann-Pick Disease Type C

Compartilhe seus vídeos com amigos, familiares e todo o mundo

Main therapies and point of action in Niemann type C disease.

Drug reformulation may improve treatment of Niemann-Pick type C disease [PreClinical]

Parents of kids with Niemann Pick C advocate for adrabetadex

Department of Surgery

Niemann-Pick Disease Type C Treatment Market Size & Trends 2020- expected to reach US$ 378.8 Million With CAGR of 42.3% by 2027, Orphazyme A/S, Cyclo Therapeutics, Inc., and Johnson & Johnson

Niemann–Pick Disease Type C

Two-Year-Old Kamryn Living with Niemann-Pick Disease Type C (NPC) - The Children's Inn at NIH

Newborn screening test developed for rare, deadly neurological disorder – Washington University School of Medicine in St. Louis

Elucidating the mechanism of cyclodextrins in the treatment of Niemann-Pick Disease Type C using crosslinked 2-hydroxypropyl-β-cyclodextrin

Recommendations on the diagnosis and management of Niemann-Pick disease type C - ScienceDirect

CTD Holdings Receives FDA Fast Track Designation for Development of Trappsol® Cyclo™ to Treat Niemann-Pick Disease Type C - International Niemann-Pick Disease Alliance (INPDA)

Niemann-Pick disease type C as a neurovisceral disease. Schematic

Gene therapy shows promise for treating Niemann-Pick disease type C1